NervGen Pharma Corp. rose 20.7% on Thursday, November 12, 2026, on 2,635,100 shares, 4.9 times its average daily volume. The headline around the move:
NervGen Pharma Corp. (NGEN:NASDAQ) closed at $1.88 on November 13, 2026, up 15.34% on the day. The stock trades 70.2% below its 52-week high of $6.30 and 46.9% above its 52-week low of $1.28. Over the past year, it lost 19.7%. NervGen Pharma Corp. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, NGEN closed higher on 120 days (48%). Its best day was November 26, 2025 (+24.68%) and its worst was May 22, 2026 (-43.48%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 4 times.
NervGen (TSXV: NGEN) (OTCQB: NGENF) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies that enable the nervous system to repair itself in settings of neurotrauma and neurologic disease. The Company is evaluating the clinical efficacy of its first- and potential best-in-class lead candidate, NVG-291, in the Phase 1b/2a CONNECT SCI Study in spinal cord injury.
Find more stocks like NGEN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.